NTA Stakeholders Meeting 2016

Nordic Trial Alliance welcomes you to the meeting “Potential in Nordic Clinical Research Cooperation”.

The meeting takes place at Hotel Bristol in Oslo January 26, 10.00-16.30. 

The theme for the meeting is to report on the outcomes of the Nordic Trial Alliance project and to discuss ways forward in Nordic clinical research. 

Very welcome!

The Nordic Trial Alliance

Please note that the meeting is free of charge but participants pay their own travel costs. Rooms may be reserved at Hotel Bristol for 1345 NOK per room and night breakfast included (one person). Please use the booking code 250116NORD_002 at the latest 18 January.


Moderator morning session: Kristján Erlendsson, Iceland

10.00 Opening
Bent Høie, Minister of Health and Care Services, Norway 

10.15  Nordic Trial Alliance – main achievements
Pierre Lafolie, Project Leader

Reports from NTA implementation projects

10.40  Nordic Research Ethical Procedures
Mika Scheinin, Professor, University of Turku, Finland 

11.00 Nordic Monitoring Network
Annette Jørgensen, Head of GCP-unit at Aalborg and Aarhus University Hospitals, Denmark

11.20 Nordic Pediatrics Network
Pirkko Lepola, Executive Secretary FINPEDMED, University of Tampere, Finland 

11.40 Nordic clinical research transparency and registration
Christian Gluud, Head of The Copenhagen Trial Unit, Rigshospitalet, Denmark 

12.00-13.00 Lunch

The potential in Nordic medical research

Moderator afternoon session Steinar Aamdal, Norway 

13.00 Present situation in the Nordic countries, tbd

13.30   A CRO perspective on what would attract more Clinical Trial to the Nordic Region
Jan Hellqvist, Regional Managing Director Northern Europe, TFS

14.00  Common Nordic Legal Framework for Future Research?
Marjut Salokannel, Legal Adviser, Finland

14.30 -14.50 Coffee

Panel discussion: The way forward in Nordic clinical research cooperation

Moderator: Pierre Lafolie, Nordic Trial Alliance 

The ethics committee perspective
Jacob Hølen, Director, The National Committee for Medical and Health Research Ethics (NEM)

The university hospital perspective
Bjørn Eiriksten, CEO, Oslo University Hospital 

The industry perspective
Mia Bengtström, Senior Adviser, Pharmaceutical Association, Finland

The research council perspective
Jørgen Frøkiær, Chairman of the Danish Council for Independent Research | Medical Sciences 

The patient organisation perspective
Ole Alexander Opdalshei, Deputy Secretary General, The Norwegian Cancer Society 

16.00 Conclusions and way forward

16.30 (at the latest) End of meeting


from 10:00 to 16:30
Registration deadline: 22.01.2016 - 17:00
The registration is closed
Maria Nilsson - Special Adviser and Leader of the Health and Welfare Programme
Contact person Maria Nilsson
Special Adviser and Leader of the Health and Welfare Programme
Work +47 993 80 264
Marianne Aastebøl Minge - Chief Operating Officer
Contact person Marianne Aastebøl Minge
Chief Operating Officer
Work +47 936 02 527